Warsaw, Poland
NCT Number: NCT02722993
Efficacy of a Probiotic Product in Children With Antibiotic-associated Gastrointestinal Disorders
To assess the effect of a probiotic product, when co-administered with antibiotics, on gastrointestinal symptoms following antibiotic treatment in children.
Looking for future studies?
Notify MeKey information
Conditions
Age range
1 year–11 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Children at the age of 1-11 years that have been prescribed antibiotic treatment.
- Problems with loose stools during earlier antibiotic treatments.
- Children whose parents or legal caregivers have signed the informed consent to participate in the study.
Exclusion criteria
- Chronic intestinal disease, immunodeficiency or immunosuppressive treatment.
- Chronic or acute diarrheal disease.
- Use of laxatives the week before inclusion in the study.
- Antibiotic treatment for the last four weeks before inclusion in the study.
- Intake of probiotic products for the last two weeks before inclusion in the study.
- Known hypersensitivity to any of the ingredients in the probiotic product or the placebo (potato starch ± bacterial culture that may contain traces of soy).
- Patient requiring hospitalisation.
Treatment and study plan
Probiotics
Dietary SupplementPlacebo
Dietary SupplementPrimary outcomes
-
Number of loose/watery stools
Time frame: 19-26 days
Sponsors and collaborators
Lead sponsor
Probi AB
Industry
Registry information
Important dates
- Study start
- 2016
- Primary completion
- 2017
- Study completion
- 2017
- First posted
- Mar 30, 2016
- Registry last updated
- Sep 26, 2018
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Evaluation of the Use of a Probiotic Containing Bifidobacterium Breve PRL2020 in Oral Drops in Preventing Side Effects From Amoxicillin or Amoxicillin/Clavulanic Acid Antibiotic Use
NCT07234448
Antibiotic-associated Diarrhea
Urbino, Italy
View Trial DetailsThe Efficacy of a Probiotic for Antibiotic Associated Gastrointestinal Symptoms
NCT05845073
Antibiotic-associated Diarrhea
Berlin, Weißenseer Weg, Germany
View Trial DetailsMechanisms of Probiotics and Antibiotic-Associated Diarrhea
NCT04414722
Antibiotic-associated Diarrhea
Washington D.C., District of Columbia, United States
View Trial DetailsEfficacy and Safety of BB-12 Supplemented Strawberry Yogurt For Healthy Children on Antibiotics
NCT03181516
Antibiotic-associated Diarrhea
Washington D.C., District of Columbia, United States
View Trial Details